Drug Shortage Report for LODALIS
| Report ID | 77834 |
| Drug Identification Number | 02373955 |
| Brand name | LODALIS |
| Common or Proper name | LODALIS |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | Colesevelam hydrochloride |
| Strength(s) | 625MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 180's |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-03-11 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2019-04-01 |
| Shortage status | Resolved |
| Updated date | 2019-04-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-04-03 | French | Compare |
| v6 | 2019-04-03 | English | Compare |
| v5 | 2019-03-15 | French | Compare |
| v4 | 2019-03-15 | English | Compare |
| v3 | 2019-03-12 | English | Compare |
| v2 | 2019-03-05 | French | Compare |
| v1 | 2019-03-05 | English | Compare |
Showing 1 to 7 of 7